FDA — authorised 23 February 2007
- Application: NDA021977
- Marketing authorisation holder: TAKEDA PHARMS USA
- Status: supplemented
🇺🇸 Vyvanse in United States
FDA authorised Vyvanse on 23 February 2007
Marketing authorisations
FDA — authorised 28 January 2017
- Application: NDA208510
- Marketing authorisation holder: TAKEDA PHARMS USA
- Status: supplemented
FDA
- Status: approved
Other Nephrology approved in United States
Frequently asked questions
Is Vyvanse approved in United States?
Yes. FDA authorised it on 23 February 2007; FDA authorised it on 28 January 2017; FDA has authorised it.
Who is the marketing authorisation holder for Vyvanse in United States?
TAKEDA PHARMS USA holds the US marketing authorisation.